Concept

CYP3A4

Cytochrome P450 3A4 (abbreviated CYP3A4) () is an important enzyme in the body, mainly found in the liver and in the intestine. It oxidizes small foreign organic molecules (xenobiotics), such as toxins or drugs, so that they can be removed from the body. It is highly homologous to CYP3A5, another important CYP3A enzyme. While many drugs are deactivated by CYP3A4, there are also some drugs which are activated by the enzyme. Some substances, such as some drugs and furanocoumarins present in grapefruit juice, interfere with the action of CYP3A4. These substances will therefore either amplify or weaken the action of those drugs that are modified by CYP3A4. CYP3A4 is a member of the cytochrome P450 family of oxidizing enzymes. Several other members of this family are also involved in drug metabolism, but CYP3A4 is the most common and the most versatile one. Like all members of this family, it is a hemoprotein, i.e. a protein containing a heme group with an iron atom. In humans, the CYP3A4 protein is encoded by the CYP3A4 gene. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q22.1. CYP3A4 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids components. The CYP3A4 protein localizes to the endoplasmic reticulum, and its expression is induced by glucocorticoids and some pharmacological agents. Cytochrome P450 enzymes metabolize approximately 60% of prescribed drugs, with CYP3A4 responsible for about half of this metabolism; substrates include acetaminophen (paracetamol), codeine, ciclosporin (cyclosporin), diazepam, and erythromycin. The enzyme also metabolizes some steroids and carcinogens. Most drugs undergo deactivation by CYP3A4, either directly or by facilitated excretion from the body. Also, many substances are bioactivated by CYP3A4 to form their active compounds, and many protoxins are toxicated into their toxic forms (see table below for examples).

Official source

https://en.wikipedia.org/wiki/CYP3A4

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related courses (1)

CH-332: Medicinal chemistry

Sitting at the crossroad of organic chemistry and medicine, this course outlines how an initial hit compound transitions into a lead candidate, and ultimately a drug, in the modern drug discovery world. Note: the course is held only during 2nd half of spr ...

Related lectures (8)

Drug Metabolism: Xenobiotics and Enzymes

Explores drug metabolism, focusing on xenobiotics, enzymes, biotransformation reactions, and factors affecting drug metabolism.

Propagation of Uncertainty: Estimation and Distribution

Discusses estimation and propagation of uncertainty in random variables and the importance of managing uncertainty in statistical analysis.

Drug-Induced Liver Injury: Mitigation Strategies

Explores Drug-Induced Liver Injury mechanisms, mitigation strategies, and challenges in drug development.

Related units (6)

Integrated Systems Laboratory (IC/STI)

Integrated Systems Laboratory (STI/IC)

Integrated Circuits Laboratory

Related concepts (31)

Cimetidine

Cimetidine, sold under the brand name Tagamet among others, is a histamine H2 receptor antagonist that inhibits stomach acid production. It is mainly used in the treatment of heartburn and peptic ulcers. The development of longer-acting H2 receptor antagonists with fewer drug interactions and adverse effects, such as ranitidine and famotidine, decreased the use of cimetidine, and though it is still used, cimetidine is no longer among the more widely used of the H2 receptor antagonists.

CYP2D6

Cytochrome P450 2D6 (CYP2D6) is an enzyme that in humans is encoded by the CYP2D6 gene. CYP2D6 is primarily expressed in the liver. It is also highly expressed in areas of the central nervous system, including the substantia nigra. CYP2D6, a member of the cytochrome P450 mixed-function oxidase system, is one of the most important enzymes involved in the metabolism of xenobiotics in the body.

Fluvoxamine

Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and obsessive–compulsive disorder (OCD), but is also used to treat anxiety disorders such as panic disorder, social anxiety disorder, and post-traumatic stress disorder.

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Official source

https://en.wikipedia.org/wiki/CYP3A4

About this result

Ontological neighbourhood

Health sciences

Anesthesiology: Anesthesia

Related courses (1)

CH-332: Medicinal chemistry

Related lectures (8)

Drug Metabolism: Xenobiotics and Enzymes

Explores drug metabolism, focusing on xenobiotics, enzymes, biotransformation reactions, and factors affecting drug metabolism.

Propagation of Uncertainty: Estimation and Distribution

Discusses estimation and propagation of uncertainty in random variables and the importance of managing uncertainty in statistical analysis.

Drug-Induced Liver Injury: Mitigation Strategies

Explores Drug-Induced Liver Injury mechanisms, mitigation strategies, and challenges in drug development.

Related publications (6)

Advancing the Understanding of Nitrous Oxide Redox-Mediated Reactions through Catalyst Engineering and Operando Multi-Spectroscopy

Nitrous oxide (N2O) is both a pollutant and a potentially valuable oxidant. Its abatement is critical because of its high global warming potential, while its activation may enable efficient partial oxidation of methane (CH4). This thesis addresses N2O abatement and utilization, moving from challenges related to NH3-engines toward active-site identification, structure-activity relationships, and reaction mechanisms. Fe-exchanged zeolites emerged as promising catalysts for N2O abatement above 400°C, but inhib

EPFL2026

Modulation of intestinal bile acids influences colonic mucosal responses

Background Elevated levels of secondary bile acids produced by the gut microbiome, in particular deoxycholic acid (DCA), influence epithelial cell proliferation and accelerate the development of colorectal cancer (CRC) under adverse dietary conditions, such as long-term, high fat intake. However, their effects on the intestinal epithelium have not been studied in detail. Aim To determine gut epithelial responses to bile acid modulation in vivo and in situ . Methods We performed targeted colonization of

Nature Research2026

Cytochrome P450-Functionalized Spinel Oxide Electrochemical Biosensors for the Enhanced Detection of Cyclophosphamide

Nanostructured metal oxides with spinel crystalline structures are highly attractive for electrochemical sensing due to their ability to enhance the catalytic activity of redox processes, improving sensitivity and lowering limits of detection. At the same time, cytochrome P450 enzymes (P450s) confer substrate specificity, enabling the selective detection of therapeutic compounds. This study investigates the integration of spinel-structured metal oxide nanoparticles—ZnCr

_{\textbf {2}}

_{\textbf {4}}

Springer Science and Business Media LLC2025

Related people (13)

Stewart Cole

Professor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.

Myriam Briki

Expertise PharmacometricsTherapeutic drug monitoringAnalytical chemistry Myriam Briki obtained her BSc from the University of Lausanne after spending her final year at Uppsala University (Sweden), where she was able to focus mainly on toxicological sciences. As a result, she chose to specialize in pharmacology and toxicology during her MSc back in Lausanne. She is now doing her PhD under the direction of Prof. Sandro Carrara (EPFL) and Dr. Monia Guidi (CHUV).Her project, carried out at the University Hospit

Johan Auwerx

Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways. Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards. Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.

Giovanni De Micheli

Expertise Design technologies for integrated systems on silicon, such as synthesis, hw/sw codesign and low-power design, as well as systems on heterogeneous platforms including electrical and biological components. Scientific Director of EcoCloud Center at EPFL Directing activities towards creating sustainable computation including AI.Designing energy-savvy data centers and edge devices. More information Please read http://si2.epfl.ch/~demichel/ Giovanni De Micheli is a research scientist in electronics and

Expertise MER and Head of Unit - Protein Production and Structure Reseach Core Facility within the Life Sciences School - PTPSP: Expertise in Integrative protein Structural Biology (mainly X-ray Crystallography and Cryo-EM) and production of macromolecules in mammalian and bacterial cells. Innovate4Life team member at SV: i4L supports the next generation of entrepreneurs through education, mentorship, and funding, to translate life sciences discoveries into technologies that benefit society. Education and

Kristina Schoonjans

Expertise Bile acid signalingNutrient sensingIntermediary metabolismMetabolic disorders Teaching & PhD PhD Students Adrien Faure Past EPFL PhD Students Pan Xu, Ece Yildiz, Nadia Bresciani, Yu Sun, Francesca Pontanari, Alejandro Alonso Calleja Past EPFL PhD Students as codirector Mitsunori Nomura, Pan Xu, Katyayanee Neopane, Lucie Camille Chanvillard, Jakob Josef Langer, Bilge Sen Elçi Courses General Biology BIOENG-110 The purpose of the course is to provide a general overview of the biolo

Karin Lederballe Meibom

Education PhD | Molecular Biology 1997 – 1997 University of Southern Denmark (Odense University), Denmark Directed by Advisor: Poul Valentin-Hansen Professionals experiences Postdoctoral researcher 2000–2004 Stanford University, USAPostdoctoral researcher 2005–2007 INSERM, Paris, FranceChargee de recherche 2007–2012 INSERM, Paris, FranceScientist Laboratory of Experimental Biophysics 2013–2014 EPFL Teaching & PhD Past EPFL PhD Students as codirector Solenne Anne